Once-daily Fluorometholone Vs Twice-daily Cyclosporine in Dry Eye Disease
Launched by KOREA UNIVERSITY ANAM HOSPITAL · Mar 9, 2025
Trial Information
Current as of April 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. participants aged 18 years or older
- • 2. complaint of dry eye symptoms for 6 months or longer at screening
- • 3. ocular surface disease index (OSDI) score of 33 or higher
- • 4. tear film breakup time of 7 seconds or less
- Exclusion Criteria:
- • 1. abnormal lid anatomy or active blepharitis
- • 2. severe systemic autoimmune diseases
- • 3. received permanent lacrimal plug within 3 months
- • 4. DED secondary to alkali burns, cicatricial pemphigoid, or Stevens-Johnson syndrome
- • 5. ocular/periocular malignancy
- • 6. active ocular allergies or allergy to the study drug or its components
- • 7. active infection
- • 8. intraocular surgery or ocular laser surgery within 6 months
- • 9. uncontrolled systemic disease or history of herpetic keratitis
- • 10. contact lens user
- • 11. intraocular pressure \>25mmHg
- • 12. pregnancy or current breast-feeding.
About Korea University Anam Hospital
Korea University Anam Hospital is a leading academic medical institution in South Korea renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies that aim to improve patient outcomes and contribute to medical knowledge. With a strong emphasis on ethical practices and patient safety, Korea University Anam Hospital collaborates with various stakeholders to facilitate cutting-edge research across diverse therapeutic areas, fostering an environment that promotes scientific discovery and translational medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported